Next-generation Testing Center of Excellence (TCoE 3.0) integrates AI,ML,and automation to make enterprise software testing faster,more responsive and efficient
12-19
Leading GreenCRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry
12-18
SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir
12-18
Collaboration among AI agents specialized in security with skills andknowledges of attacks and protection
12-18
NEW YORK,Dec. 13,2024-- Maitong Sunshine Cultural Development Co.,Ltd (OTCQB: MGSD),an enterprise that provides cultural tourism services and other related services and products,announced its financia
12-18
Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC)
12-18
BEIJING,Dec. 13,2024-- A report from People\'s Daily: In July this year,the Shanghai Oriental Art Center (SHOAC) Citizens\' Concert celebrated its 18th anniversary. As the curtain rose,Chinese conduct
12-18
FREMONT,Calif.,Dec. 14,2024-- Anviz (a business unit of Xthings Group,Inc.) has officially launched an OSDP (Open Supervisory Device Protocol)-enabled access control solution. Our goal is simple: impr
12-18
- Twinit Unveils 3D Vision-Based AI Skin Analysis,Wins CES 2024 Innovation Award SEOUL,South Korea,Dec. 13,2024-- EntreReality,a digital human startup headquartered in South Korea,has launched Twinit
12-18
SHENZHEN,China,Dec. 16,2024-- The holidays are here,andTopzee is ready to help you celebrate both Christmas and the New Year with effortless cooking and unforgettable moments. Our top-tier kitchen app
12-18
Bortala Mongolian Autonomous Prefecture 220 kV Xinhua South Gathering Station successfully delivered electricity
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
Health In Tech Announces Closing of Initial Public Offering
Higer New V Series, Leading Bus New Trend
©copyright2009-2020Fresh life